Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Roszik

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Human Vaccines & Immunotherapeutics|January 26, 2017
Targeting iNOS to increase efficacy of immunotherapiesSuhendan Ekmekcioglu, Elizabeth A Grimm, Jason Roszik
Cancer Discovery|March 16, 2021
Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic ApproachesRavi G Gupta, Fenge Li, Jason Roszik, et al.
JCO Precision Oncology|September 11, 2020
Precision Oncology in Sarcomas: Divide and ConquerRoberto Carmagnani Pestana, Roman Groisberg, Jason Roszik, et al.
Frontiers in Immunology|August 1, 2018
Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational ImmunotherapyYiliang Li, Sapna Pradyuman Patel, Jason Roszik, et al.
Plos One|April 29, 2017
A tool for discovering drug sensitivity and gene expression associations in cancer cellsYong Qin, Anthony P Conley, Elizabeth A Grimm, et al.
Frontiers in Oncology|April 5, 2018
Impact of l-Arginine Metabolism on Immune Response and Anticancer ImmunotherapySun-Hee Kim, Jason Roszik, Elizabeth A Grimm, et al.
Case Reports in Oncology|February 23, 2019
Beyond KRAS: Practical Molecular Targets in Pancreatic AdenocarcinomaAlbert Grinshpun, Yonaton Zarbiv, Jason Roszik, et al.
Molecular Therapy. Methods & Clinical Development|July 12, 2017
In Silico Restriction Enzyme Digests to Minimize Mapping Bias in Genomic SequencingJason Roszik, György Fenyőfalvi, László Halász, et al.
Cancers|April 3, 2021
Targeting <i>KRAS</i> in Cancer: Promising Therapeutic StrategiesLisa Maria Mustachio, Anca Chelariu-Raicu, Lorant Szekvolgyi, et al.
Investigational New Drugs|August 3, 2021
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumorsLimin Zhu, Brian Hobbs, Jason Roszik, et al.
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Human Vaccines & Immunotherapeutics|January 26, 2017
Targeting iNOS to increase efficacy of immunotherapiesSuhendan Ekmekcioglu, Elizabeth A Grimm, Jason Roszik
Cancer Discovery|March 16, 2021
Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic ApproachesRavi G Gupta, Fenge Li, Jason Roszik, et al.
JCO Precision Oncology|September 11, 2020
Precision Oncology in Sarcomas: Divide and ConquerRoberto Carmagnani Pestana, Roman Groisberg, Jason Roszik, et al.
Frontiers in Immunology|August 1, 2018
Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational ImmunotherapyYiliang Li, Sapna Pradyuman Patel, Jason Roszik, et al.
Plos One|April 29, 2017
A tool for discovering drug sensitivity and gene expression associations in cancer cellsYong Qin, Anthony P Conley, Elizabeth A Grimm, et al.
Frontiers in Oncology|April 5, 2018
Impact of l-Arginine Metabolism on Immune Response and Anticancer ImmunotherapySun-Hee Kim, Jason Roszik, Elizabeth A Grimm, et al.
Case Reports in Oncology|February 23, 2019
Beyond KRAS: Practical Molecular Targets in Pancreatic AdenocarcinomaAlbert Grinshpun, Yonaton Zarbiv, Jason Roszik, et al.
Molecular Therapy. Methods & Clinical Development|July 12, 2017
In Silico Restriction Enzyme Digests to Minimize Mapping Bias in Genomic SequencingJason Roszik, György Fenyőfalvi, László Halász, et al.
Cancers|April 3, 2021
Targeting <i>KRAS</i> in Cancer: Promising Therapeutic StrategiesLisa Maria Mustachio, Anca Chelariu-Raicu, Lorant Szekvolgyi, et al.
Investigational New Drugs|August 3, 2021
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumorsLimin Zhu, Brian Hobbs, Jason Roszik, et al.
Pageof 17